The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
De novo mutations of voltage-gated sodium channel α II gene SCN2A in intractable epilepsies
Open accessAbstract
BACKGROUND: Mutations of voltage-gated sodium channel alpha(II) gene, SCN2A, have been described in a wide spectrum of epilepsies. While inherited SCN2A mutations have been identified in multiple mild epilepsy cases, a de novo SCN2A-R102X mutation, which we previously reported in a patient with sporadic intractable childhood localization-related epilepsy, remains unique. To validate the involvement of de novo SCN2A mutations in the etiology of intractable epilepsies, we sought to identify additional instances. METHODS: We performed mutational analyses on SCN2A in 116 patients with severe myoclonic epilepsy in infancy, infantile spasms, and other types of intractable childhood partial and generalized epilepsies and did whole-cell patch-clamp recordings on Na(v)1.2 channels containing identified mutations. RESULTS: We discovered 2 additional de novo SCN2A mutations. One mutation, SCN2A-E1211K, was identified in a patient with sporadic infantile spasms. SCN2A-E1211K produced channels with altered electrophysiologic properties compatible with both augmented (an approximately 18-mV hyperpolarizing shift in the voltage dependence of activation) and reduced (an approximately 22-mV hyperpolarizing shift in the voltage dependence of steady-state inactivation and a slowed recovery from inactivation) channel activities. The other de novo mutation, SCN2A-I1473M, was identified in a patient with sporadic neonatal epileptic encephalopathy. SCN2A-I1473M caused an approximately 14-mV hyperpolarizing shift in the voltage dependence of activation. CONCLUSIONS: The identified de novo mutations SCN2A-E1211K, -I1473M, and -R102X indicate that SCN2A is an etiologic candidate underlying a variety of intractable childhood epilepsies. The phenotypic variations among patients might be due to the different electrophysiologic properties of mutant channels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some reports have described clinical improvement with less mainstream medications, including lidocaine in children with infantile epileptic encephalopathy [56,57], ethosuximide for late-onset seizures [25], and acetazolamide for episodic ataxia [28,29], though data on the generalizability of these effects are limited.”
From Progress in Understanding and Treating SCN2A-Mediated Disorders (2018) · cites this paper as [56]
The cited source says what the claim attributes to it.
In the citing paper
“While the observation of seizure improvement is based only on retrospective clinical review, this finding reinforces previous observations of drug response: withdrawal of phenytoin provoking status epilepticus in one case, status treated with fosphenytoin in another, 2 seizure-free on lamotrigine, and one with seizure control on lidocaine.6,12,14”
From SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures (2015) · cites this paper as [6]
In the citing paper
“The second strongest overall association, with two truncating mutations in ASD cases and three such mutations in ID cases, is SCN2A, a gene previously associated with epilepsy and seizure disorders [52,53].”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292
Yu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A. (2006) · Nature Neuroscience · doi:10.1038/nn1754 · Cited by 1,173
Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2
Escayg, A., MacDonald, B. T., Meisler, M. H., Baulac, S., Huberfeld, G., An-Gourfinkel, I., Brice, A., LeGuern, E., Moulard, B., Chaigne, D., et al. (2000) · Nature Genetics · doi:10.1038/74159 · Cited by 996
Ogiwara, I., Miyamoto, H., Morita, N., Atapour, N., Mazaki, E., Inoue, I., Takeuchi, T., Itohara, S., Yanagawa, Y., Obata, K., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5270-06.2007 · Cited by 879
Self-citationScheffer, I. E. (1997) · Brain · doi:10.1093/brain/120.3.479 · Cited by 758
The spectrum of SCN1A-related infantile epileptic encephalopathies
Harkin, L. A., McMahon, J. M., Iona, X., Dibbens, L. M., Pelekanos, J. T., Zuberi, S. M., Sadleir, L. G., Andermann, E., Gill, D. S., Farrell, K., et al. (2007) · Brain · doi:10.1093/brain/awm002 · Cited by 530
Sodium channel mutations in epilepsy and other neurological disorders
Meisler, M. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25466 · Cited by 512
Sodium-channel defects in benign familial neonatal-infantile seizures
Heron, S. E., Crossland, K. M., Andermann, E., Phillips, H. A., Hall, A. J., Bleasel, A., Shevell, M. I., Mercho, S., Seni, M., Guiot, M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09968-3 · Cited by 378
Sugawara, T., Tsurubuchi, Y., Agarwala, K. L., Ito, M., Fukuma, G., Mazaki-Miyazaki, E., Nagafuji, H., Noda, M., Imoto, K., Wada, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111065098 · Cited by 378
Self-citationMulley, J. C., Scheffer, I. E., Petrou, S., Dibbens, L. M., Berkovic, S. F., & Harkin, L. A. (2005) · Human Mutation · doi:10.1002/humu.20178 · Cited by 351
Fujiwara, T. (2003) · Brain · doi:10.1093/brain/awg053 · Cited by 345
Self-citationBenign familial neonatal‐infantile seizures: Characterization of a new sodium channelopathy
Berkovic, S. F., Heron, S. E., Giordano, L., Marini, C., Guerrini, R., Kaplan, R. E., Gambardella, A., Steinlein, O. K., Grinton, B. E., Dean, J. T., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20029 · Cited by 285
Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy
Sugawara, T., Mazaki-Miyazaki, E., Fukushima, K., 下村, 次., Fujiwara, T., Hamano, S., Inoue, Y., & Yamakawa, K. (2002) · Neurology · doi:10.1212/wnl.58.7.1122 · Cited by 235
Self-citationKamiya, K., Kaneda, M., Sugawara, T., Mazaki, E., Okamura, N., Montal, M., Makita, N., Tanaka, M., Fukushima, K., Fujiwara, T., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3089-03.2004 · Cited by 199
Self-citationSodium channel α1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms
Wallace, R. H., Hodgson, B. L., Grinton, B. E., Gardiner, R. M., Robinson, R. A., Rodriguez‐Casero, V., Sadleir, L. G., Morgan, J. P., Harkin, L. A., Dibbens, L. M., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000086379.71183.78 · Cited by 190
Fukuma, G., Oguni, H., Shirasaka, Y., Watanabe, K., Miyajima, T., Yasumoto, S., Ohfu, M., Inoue, T., Watanachai, A., Kira, R., et al. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.15103.x · Cited by 186
Neuronal Death and Perinatal Lethality in Voltage-Gated Sodium Channel αII-Deficient Mice
Planells‐Cases, R., Caprini, M., Zhang, J., Rockenstein, E. M., Rivera, R. R., Murre, C., Masliah, E., & Montal, M. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76829-9 · Cited by 168
Self-citationNa v 1.1 mutations cause febrile seizures associated with afebrile partial seizures
Sugawara, T., Mazaki-Miyazaki, E., Ito, M., Nagafuji, H., Fukuma, G., Mitsudome, A., Wada, K., Kaneko, S., Hirose, S., & Yamakawa, K. (2001) · Neurology · doi:10.1212/wnl.57.4.703 · Cited by 149
Self-citationScalmani, P., Rusconi, R., Armatura, E., Zara, F., AVANZINI, G., Franceschetti, S., & Mantegazza, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2476-06.2006 · Cited by 122
SCN2A Mutations and Benign Familial Neonatal‐Infantile Seizures: The Phenotypic Spectrum
Herlenius, E., Heron, S. E., Grinton, B. E., Keay, D., Scheffer, I. E., Mulley, J. C., & Berkovic, S. F. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01049.x · Cited by 118
Somatic and germline mosaicisms in Severe Myoclonic Epilepsy of Infancy
Gennaro, E., Santorelli, F. M., Bertini, E., Buti, D., Gaggero, R., Gobbi, G., Lini, M., Granata, T., Freri, E., Parmeggiani, A., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.209 · Cited by 108
Depienne, C., Arzimanoglou, A. A., Trouillard, O., Fédirko, E., Baulac, S., Saint‐Martin, C., Ruberg, M., Dravet, C., Nabbout, R., Baulac, M., et al. (2006) · Human Mutation · doi:10.1002/humu.9419 · Cited by 106
Sodium channel mRNAs I, II and III in the CNS: cell-specific expression
Black, J. A., Yokoyama, S., Higashida, H., Ransom, B. R., & Waxman, S. G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90056-6 · Cited by 106
Misra, S. N., Kahlig, K. M., & George, A. L. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01619.x · Cited by 104
Xu, R., Thomas, E. A., Jenkins, M., Gazina, E. V., Chiu, C., Heron, S. E., Mulley, J. C., Scheffer, I. E., Berkovic, S. F., & Petrou, S. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.03.003 · Cited by 84
A Novel SCN2A Mutation in Family with Benign Familial Infantile Seizures
Striano, P., Bordo, L., Lispi, M. L., Specchio, N., Minetti, C., Vigevano, F., & Zara, F. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00392.x · Cited by 83
Mosaic SCN1A Mutation in Familial Severe Myoclonic Epilepsy of Infancy
Marini, C., Mei, D., Cross, J. H., & Guerrini, R. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00675.x · Cited by 79
SCN1AMutation Mosaicism in a Family with Severe Myoclonic Epilepsy in Infancy
Morimoto, M., Mazaki, E., Nishimura, A., Chiyonobu, T., Sawai, Y., Murakami, A., Nakamura, K., Inoue, I., Ogiwara, I., Sugimoto, T., et al. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00645.x · Cited by 67
Self-citationDistribution of I, II and III subtypes of voltage-sensitive Na+ channel mRNA in the rat brain
Furuyama, T., Morita, Y., Inagaki, S., & Takagi, H. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90087-6 · Cited by 59
Lidocaine‐dependent Early Infantile Status Epilepticus with Highly Suppressed EEG
Sawaishi, Y., Yano, T., Enoki, M., & Takada, G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.25301.x · Cited by 19
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2646 · Cited by 687
Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders
Wolff, M., Johannesen, K. M., Hedrich, U. B. S., Masnada, S., Rubboli, G., Gardella, E., Lesca, G., Ville, D., Milh, M., Villard, L., et al. (2017) · Brain · doi:10.1093/brain/awx054 · Cited by 600
Neurodevelopmental disorders—the history and future of a diagnosticconcept
Morris-Rosendahl, D. J., & Crocq, M. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.1/macrocq · Cited by 607
De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies
Appenzeller, S., Balling, R., Barisic, N., Baulac, S., Caglayan, H., Craiu, D., De Jonghe, P., Depienne, C., Dimova, P., Djémié, T., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.08.013 · Cited by 439
Metadata
- Authors
- Ogiwara, I., Ito, K., Sawaishi, Y., Osaka, H., Mazaki, E., Inoue, I., Montal, M., Hashikawa, T., Shike, T., Fujiwara, T., Inoue, Y., Kaneda, M., & Yamakawa, K.
- Affiliations
- Akita University (JP)
- Venue
- Neurology
- Published
- 2009-09-29
- Volume
- 73
- Issue
- 13
- Pages
- 1046-1053
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC2754324
- OpenAlex
- W2061682874
- Cited by
- 205
- References
- 30
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 8 · 2021: 16 · 2020: 14 · 2019: 18 · 2018: 14 · 2017: 15 · 2016: 12 · 2015: 18 · 2014: 21 · 2013: 14 · 2012: 11
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
- Fukuoka University
- Hirosaki University
- National Institutes of Health
- RIKEN
- National Institute of General Medical Sciences (GM-49711, R01GM049711)
- RIKEN Brain Science Institute
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- SCN2A, de novo mutations, drug-resistant epilepsy, infantile spasms, Dravet syndrome, neonatal epileptic encephalopathy, voltage dependence of activation, channel inactivation, recovery from inactivation, genotype-phenotype correlation
- MeSH terms
- Amino Acid Sequence, Cell Line, DNA Mutational Analysis, Epilepsies, Myoclonic, Female, Haplotypes, Humans, Infant, Newborn, Kidney, Male, Nerve Tissue Proteins, Severity of Illness Index, Spasms, Infantile, Transfection, Sodium Channels, Conserved Sequence, Protein Structure, Tertiary, Fatal Outcome, Patch-Clamp Techniques, Mutation, Missense, Young Adult, NAV1.2 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
